Company Macro Group Pharmaceuticals (Macro Capital) S.A.E

MCRO

EGS7D971C011

Pharmaceuticals

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Annual profits - Rate of surprise

Sector Other Pharmaceuticals

MACRO GROUP PHARMACEUTICALS (MACRO CAPITAL) S.A.E

End-of-day quote Egyptian Exchange Other stock markets 03:30:00 16/05/2024 am IST			5-day change	1st Jan Change
2.13 ^EGP	+3.40%		-1.84%	-27.80%

16/04	Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Macro Group Pharmaceutical S.A.E. (Macro Capital) is specialized in developing, manufacturing and marketing pharmaceuticals. The company's products include anti-scar, skincare, antiseptic, hair care, oral care and muscle relaxant medicines. In addition, the group offers plant-based medicines.

At the end of 2021, Macro Group Pharmaceutical S.A.E. (Macro Capital) had one production site in Egypt.

EGP in Million	2022	Weight	2023	Weight	Delta
Pharmaceutical Products, Cosmetics, Sterilizers, Printing Works, and Production of Advertising and Packing and Packaging Materials 100.0 %	730	100.0 %	526	100.0 %	-27.91%

EGP in Million	2022	Weight	2023	Weight	Delta
Egypt 100.0 %	730	100.0 %	526	100.0 %	-27.91%

Managers	Title	Age	Since
Hisham Wasfy CEO	Chief Executive Officer	-	01/19/01
Ashraf Hamdy DFI	Director of Finance/CFO	-	01/19/01
Zeina Shahin IRC	Investor Relations Contact	-	-
Tamer Raouf SAM	Sales & Marketing	-	01/22/01
Mahmoud El Nayeb PRN	Corporate Officer/Principal	-	-
Sherine Mostafa HRO	Human Resources Officer	-	-
Mohamed Yakout PRN	Corporate Officer/Principal	-	-
Mohamed Azzazy SAM	Sales & Marketing	-	-

Members of the board	Title	Age	Since
Sahar El-Sallab BRD	Director/Board Member	-	01/21/01
Ahmed Badreldin BRD	Director/Board Member	52	01/21/01
Ahmed El-Nayeb FOU	Founder	-	01/02/01
Samia Bahauddin El Baroudi BRD	Director/Board Member	36	01/21/01
Conor Mcnaughton BRD	Director/Board Member	44	01/21/01
Ahmed Rady BRD	Director/Board Member	-	01/18/01
Hisham Wasfy CEO	Chief Executive Officer	-	01/19/01
Tamir Saeed BRD	Director/Board Member	-	01/21/01
Norbert Lurz BRD	Director/Board Member	-	01/21/01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	570,206,455	154,098,266 ( 27.02 %)	8,100,000 ( 1.421 %)	27.02 %

Name	Equities	%	Valuation
Rudiarius Capital Management (Pty) Ltd. 0.2363 %	1,347,570	0.2363 %	58 579 £

Macro Group Pharmaceutical SAE

83, Al Moltaka Al Arabi Tower 2 & 3

, Sheraton

http://www.macro-egy.com

address Macro Group Pharmaceuticals (Macro Capital) S.A.E(MCRO)

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2.13 EGP

Average target price

5.3 EGP

Spread / Average Target

+148.83%

Consensus

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
MACRO GROUP PHARMACEUTICALS (MACRO CAPITAL) S.A.E	-27.80%	25.57M
ELI LILLY AND COMPANY	+32.09%	694B
NOVO NORDISK A/S	+29.39%	593B
JOHNSON & JOHNSON	-1.34%	371B
MERCK & CO., INC.	+20.34%	331B
ABBVIE INC.	+7.39%	290B
ASTRAZENECA PLC	+14.25%	239B
ROCHE HOLDING AG	-3.03%	209B
NOVARTIS AG	+10.02%	209B
AMGEN INC.	+8.49%	169B

Other Pharmaceuticals